Y. Cheng, “The Valuation and Strategic Role of Amgen as an Anchor Stock in the Biopharmaceutical Industry Under Market Volatility”, JID, vol. 13, no. 1, pp. 294–300, Nov. 2025, doi: 10.54097/am35dd94.